Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

DElirium and LIGHT: Exploring Modifiable Risk Factors of Delirium - a Pilot Study (DELIGHT-P)

24 agosto 2026 aggiornato da: King's College Hospital NHS Trust

After a period of critical illness many people develop problems with memory, attention and thinking and this can make daily life more difficult. A risk factor for these problems is delirium. Delirium is a sudden change in the brain that causes confusion and difficulty focusing. People develop delirium when they are sick for another reason, such as a severe infection, or after surgery. Other risk factors for delirium are altered sleep/wake cycle, and absence of daylight. While delirium is very common in critical care, it's difficult to recognise and the reasons why it happens are not fully understood.

There are no treatments for delirium. Management focusses on reducing the impact of things that make it more likely for someone to develop delirium. For example, by making sure pain is well controlled and that family members can visit. While it comes with its challenges, maintaining a normal day and night cycle by turning lights off and reducing the number of interruptions during nighttime hours is also a strategy used and research has shown that sometimes this works. Unfortunately, the findings are not the same in every study, and the reasons why these interventions work to reduce delirium are not explored.

This study, called DELIGHT-P, wants to look at the relationship between delirium and light exposure to help to understand why absence of daylight is a risk factor for delirium. We think it has something to do with changes in the 'body clock' of patients in critical care. To find this out we will collect blood samples, measure light levels at the bedside, and assess participants for delirium. After discharge from critical care we will see participants again and ask them about their memory and do some thinking tests. We will also do another blood test. The blood samples will be tested for markers of changes to the 'body clock' and others will be tested for proteins that might be useful for recognising when someone has delirium.

As this is a pilot study, the research will be done with fewer people taking part. This is to check that the things we want to measure are the right things, and that it's possible to do the research. We hope that in the future we can do a larger study to be able to draw conclusions about what we find. The findings from this study may help us understand how light exposure and an altered body clock contributes to developing delirium. By checking for proteins that might be present in patients who have delirium, it might help us understand what processes are happening in the body to cause delirium. It is possible that through this work, we can identify potential treatment targets for delirium.

We hope that by doing this, we may be able to improve some of the memory and thinking problems that people have after a stay in critical care.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Descrizione dettagliata

Background:

Delirium is a neuropsychiatric syndrome characterised by acute deficits in attention and other aspects of cognition. Patients with delirium have altered arousal, often displaying signs of hypervigilance and agitation, or indeed reduced levels of consciousness that look like coma. Many experience troubling symptoms in the form of hallucinations or delusions. Delirium is associated with longer hospital stays, increased mortality and long term cognitive impairment.

Delirium is highly prevalent in acute hospital environments. In critical care, it is reported that up to 70% of patients have delirium. Despite this, the mechanisms underpinning its onset and persistence are poorly understood. Recent evidence suggests that disruption in circadian rhythms - through altered light exposure, noise and sleep disturbance - may play a role in it's pathophysiology. There have been few studies which have directly measured light intensity and quality within clinical settings and correlated this to markers of circadian disruption and explored how this interacts with delirium risk.

In recent years, markers of neuronal damage have shown promise in helping to detect delirium, and understand the pathophysiological mechanisms underpinning it, but more work is needed to explore their use in critically ill patients at risk of delirium.

DELIGHT-P (DElirium and LIGHT: Exploring modifiable risk factors and mechanisms of delirium - A Pilot Study) is a pilot for a prospective observational cohort study. This observational cohort study will describe patterns of light exposure, endocrine rhythms, and delirium incidence in critically ill patients.

Results from this programme of work will inform the design of a powered observational study and potentially future studies examining whether circadian based interventions can reduce delirium incidence and improve outcomes. Beyond the critical care environment, the findings will support specialties across the NHS where delirium is highly prevalent, as well as guide hospital and critical care design, informing evidence-based policies on light exposure and sleep promoting care.

Importantly, findings from this work may also elucidate some of the mechanisms of delirium, offering insight to what is currently a very challenging syndrome with significant consequences.

Primary Objective:

To assess the feasibility of carrying out a study that exploring modifiable risk factors of delirium. To do this we will assess the recruitment capability, retention rate and evaluate the data collection procedures.

Secondary Objectives

  • To explore the relationship between light exposure, altered circadian rhythms and delirium in critically ill patients.
  • To explore the association between serum markers of inflammation, neuronal damage and delirium
  • To explore the cognitive outcomes of critically ill patients and the relationship with markers of neuronal damage.

Tipo di studio

Osservativo

Iscrizione (Stimato)

10

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • London, Regno Unito
        • Reclutamento
        • King's College Hospital NHS Foundation Trust
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Adult patients in critical care

Descrizione

Inclusion Criteria:

  • Adult patients >50 years old
  • Patients admitted to critical care in previous 24 hours
  • Patients with an arterial or venous access line suitable for blood sampling
  • Patients with an expected length of stay >36 hours

Exclusion Criteria:

  • Patients with a primary neurosurgical diagnosis
  • Patients with pre-existing cognitive impairment
  • Patients expected to die within 24 hours or receiving end of life treatment

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

Coorti e interventi

Gruppo / Coorte
Patients in critical care
Patients receiving care in critical care

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Lasso di tempo
Recruitment and retention
Lasso di tempo: 6 months
6 months
Adherence to study procedures
Lasso di tempo: 6 months
6 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 agosto 2026

Completamento primario (Stimato)

1 febbraio 2027

Completamento dello studio (Stimato)

1 maggio 2027

Date di iscrizione allo studio

Primo inviato

24 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

24 agosto 2026

Primo Inserito (Effettivo)

28 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

28 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

24 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • KCH26-023
  • 367559 (Altro identificatore: IRAS)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .